INR Management of an Antiphospholipid Syndrome Patient With Point-of-Care INR Testing.

Dush, Aaron; Erdeljac, H Paige

Dush, Aaron; Erdeljac, H Paige.

Affiliation

Dush A; Department of Pharmacy, The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA.
Erdeljac HP; Department of Pharmacy, The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA.

J Pharm Pract ; 33(3): 390-391, 2020 Jun.

Article in En | MEDLINE | ID: mdl-30917725

Subject(s)

Antiphospholipid Syndrome; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome/diagnosis; Antiphospholipid Syndrome/drug therapy; Female; Humans; International Normalized Ratio; Point-of-Care Systems

Key words

INR; antiphospholipid syndrome; lupus anticoagulant; warfarin

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiphospholipid Syndrome Type of study: Diagnostic_studies Limits: Female / Humans Language: En Journal: J Pharm Pract Journal subject: FARMACIA Year: 2020 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google